Targeting the glycan of receptor binding domain with jacalin as a novel approach to developing treatment against COVID-19
<p><i><span>In silico</span></i><span> analysis revealed that a lectin, jacalin from jackfurit seeds recognize glycosylated region of receptor binding domain (RBD) of COVID-19. Jacalin binding induce conformational changes in RBD and significantly affect its interaction with human angiotensin-converting enzyme 2. The result may open up exploration of lectins based strategies against COVID-19.</span><i><span>In silico</span></i><span> analysis revealed that a lectin, jacalin from jackfurit seeds recognize glycosylated region of receptor binding domain (RBD) of COVID-19. Jacalin binding induce conformational changes in RBD and significantly affect its interaction with human angiotensin-converting enzyme 2. The result may open up exploration of lectins based strategies against COVID-19.</span></p>
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 0
- Harmonization
- 12
- Access
- 12
- Reuse readiness
- 0
- Engagement
- 4
Dataset details
- Repository
- dryad
- Published
- August 23, 2020
- License
- cc-zero
- DOI
- 10.5061/dryad.9kd51c5dk
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.